{"id":827702,"date":"2022-10-17T19:01:10","date_gmt":"2022-10-17T17:01:10","guid":{"rendered":"https:\/\/bebeez.it\/non-categorizzato\/inversago-pharma-raises-95-million-cad-in-series-c-financing\/"},"modified":"2022-10-17T19:01:10","modified_gmt":"2022-10-17T17:01:10","slug":"inversago-pharma-raises-95-million-cad-in-series-c-financing","status":"publish","type":"post","link":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/inversago-pharma-raises-95-million-cad-in-series-c-financing\/","title":{"rendered":"Inversago Pharma Raises $95 million CAD in Series C Financing"},"content":{"rendered":"- Series C financing led by NEA\n\n\n- Provides advancement of INV-202 Phase 2 clinical trial in Diabetic Kidney Disease in Q4\n\nMONTREAL--(BUSINESS WIRE)--#AmgenVentures--Inversago Pharma Inc. (\u201cInversago\u201d), a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists, today announced the completion of a Series C funding of $95 million CAD (approximately $70 million USD), led by New Enterprise Associates (\u201cNEA\u201d). Additional new investors Forbion\u2019s Growth Opportunities Fund (\u201cForbion Growth\u201d) and Amgen Ventures joined current investors including Forbion\u2019s Ventures Fund IV (\u201cForbion Ventures\u201d), Fonds de solidarit\u00e9 FTQ, Genesys Capital, AmorChem, JDRF T1D Fund and adMare BioInnovations
Abbonati<\/a> o Accedi<\/a> per leggere il resto di questo contenuto.<\/div><\/div>","protected":false},"excerpt":{"rendered":"

– Series C financing led by NEA – Provides advancement of INV-202 Phase 2 clinical trial in Diabetic Kidney Disease in Q4 MONTREAL–(BUSINESS WIRE)–#AmgenVentures–Inversago Pharma Inc. (\u201cInversago\u201d), a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists, today announced the completion of a Series C funding of $95 million CAD (approximately […]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49625],"tags":[],"settori":[],"slider_categorie_and_home_page":[],"class_list":["post-827702","post","type-post","status-publish","format-standard","hentry","category-private-capital-in-north-america"],"acf":[],"yoast_head":"\nInversago Pharma Raises $95 million CAD in Series C Financing - BeBeez<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/inversago-pharma-raises-95-million-cad-in-series-c-financing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Inversago Pharma Raises $95 million CAD in Series C Financing - BeBeez\" \/>\n<meta property=\"og:description\" content=\"- Series C financing led by NEA - Provides advancement of INV-202 Phase 2 clinical trial in Diabetic Kidney Disease in Q4 MONTREAL--(BUSINESS WIRE)--#AmgenVentures--Inversago Pharma Inc. (\u201cInversago\u201d), a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists, today announced the completion of a Series C funding of $95 million CAD (approximately […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/inversago-pharma-raises-95-million-cad-in-series-c-financing\/\" \/>\n<meta property=\"og:site_name\" content=\"BeBeez\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-17T17:01:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"683\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/inversago-pharma-raises-95-million-cad-in-series-c-financing\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/inversago-pharma-raises-95-million-cad-in-series-c-financing\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Inversago Pharma Raises $95 million CAD in Series C Financing\",\"datePublished\":\"2022-10-17T17:01:10+00:00\",\"dateModified\":\"2022-10-17T17:01:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/inversago-pharma-raises-95-million-cad-in-series-c-financing\/\"},\"wordCount\":769,\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"articleSection\":[\"Private capital in North America\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/inversago-pharma-raises-95-million-cad-in-series-c-financing\/\",\"url\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/inversago-pharma-raises-95-million-cad-in-series-c-financing\/\",\"name\":\"Inversago Pharma Raises $95 million CAD in Series C Financing - BeBeez\",\"isPartOf\":{\"@id\":\"https:\/\/15.161.165.86\/#website\"},\"datePublished\":\"2022-10-17T17:01:10+00:00\",\"dateModified\":\"2022-10-17T17:01:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/inversago-pharma-raises-95-million-cad-in-series-c-financing\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/inversago-pharma-raises-95-million-cad-in-series-c-financing\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/inversago-pharma-raises-95-million-cad-in-series-c-financing\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bebeez.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Inversago Pharma Raises $95 million CAD in Series C Financing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/15.161.165.86\/#website\",\"url\":\"https:\/\/15.161.165.86\/\",\"name\":\"BeBeez\",\"description\":\"BeBeez\",\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/15.161.165.86\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/15.161.165.86\/#organization\",\"name\":\"BeBeez\",\"url\":\"https:\/\/15.161.165.86\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"contentUrl\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"width\":309,\"height\":122,\"caption\":\"BeBeez\"},\"image\":{\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Inversago Pharma Raises $95 million CAD in Series C Financing - BeBeez","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/inversago-pharma-raises-95-million-cad-in-series-c-financing\/","og_locale":"en_US","og_type":"article","og_title":"Inversago Pharma Raises $95 million CAD in Series C Financing - BeBeez","og_description":"- Series C financing led by NEA - Provides advancement of INV-202 Phase 2 clinical trial in Diabetic Kidney Disease in Q4 MONTREAL--(BUSINESS WIRE)--#AmgenVentures--Inversago Pharma Inc. (\u201cInversago\u201d), a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists, today announced the completion of a Series C funding of $95 million CAD (approximately […]","og_url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/inversago-pharma-raises-95-million-cad-in-series-c-financing\/","og_site_name":"BeBeez","article_published_time":"2022-10-17T17:01:10+00:00","og_image":[{"width":683,"height":242,"url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/inversago-pharma-raises-95-million-cad-in-series-c-financing\/#article","isPartOf":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/inversago-pharma-raises-95-million-cad-in-series-c-financing\/"},"author":{"name":"","@id":""},"headline":"Inversago Pharma Raises $95 million CAD in Series C Financing","datePublished":"2022-10-17T17:01:10+00:00","dateModified":"2022-10-17T17:01:10+00:00","mainEntityOfPage":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/inversago-pharma-raises-95-million-cad-in-series-c-financing\/"},"wordCount":769,"publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"articleSection":["Private capital in North America"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/inversago-pharma-raises-95-million-cad-in-series-c-financing\/","url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/inversago-pharma-raises-95-million-cad-in-series-c-financing\/","name":"Inversago Pharma Raises $95 million CAD in Series C Financing - BeBeez","isPartOf":{"@id":"https:\/\/15.161.165.86\/#website"},"datePublished":"2022-10-17T17:01:10+00:00","dateModified":"2022-10-17T17:01:10+00:00","breadcrumb":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/inversago-pharma-raises-95-million-cad-in-series-c-financing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bebeez.it\/en\/private-capital-in-north-america\/inversago-pharma-raises-95-million-cad-in-series-c-financing\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/inversago-pharma-raises-95-million-cad-in-series-c-financing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bebeez.it\/en\/"},{"@type":"ListItem","position":2,"name":"Inversago Pharma Raises $95 million CAD in Series C Financing"}]},{"@type":"WebSite","@id":"https:\/\/15.161.165.86\/#website","url":"https:\/\/15.161.165.86\/","name":"BeBeez","description":"BeBeez","publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/15.161.165.86\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/15.161.165.86\/#organization","name":"BeBeez","url":"https:\/\/15.161.165.86\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/","url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","contentUrl":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","width":309,"height":122,"caption":"BeBeez"},"image":{"@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/827702","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/comments?post=827702"}],"version-history":[{"count":0,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/827702\/revisions"}],"wp:attachment":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/media?parent=827702"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/categories?post=827702"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/tags?post=827702"},{"taxonomy":"settori","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/settori?post=827702"},{"taxonomy":"slider_categorie_and_home_page","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/slider_categorie_and_home_page?post=827702"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}